Life Science Platform Licensing Network

Where proprietary platforms find their ideal partners

The Partnership Tree is a curated network where life science companies actively promote their proprietary technology platforms, IP and partnership opportunities to Alliance, Technology & BD professionals worldwide. Every listing is verified, intentional, and actively seeking engagement.

Browse Platforms → List Your Platform
20
Curated platform technologies actively seeking partners
3,000+
Life science companies in our broader partnership network
12+
Countries represented across featured platforms
100%
Verified active partnership intent — no stale listings
Why The Partnership Tree
🎯

Curated, not crawled

Every platform here is hand-selected for clear partnership intent, proprietary IP, and verified profile completeness. No noise, no generic AI-scraped listings.

🤝

Intent, not just presence

Companies declare exactly what they're seeking — licence partners, co-development, geographic rights — so BD professionals can act on the information immediately.

🔍

Found where it matters

Your platform surfaces in precise keyword searches by life science BD professionals who know what they're looking for — not buried in generic search results.

Featured Platform Opportunities

Proprietary technologies actively seeking licensing and co-development partners
20 platforms
All Platforms AI Drug Discovery Cell Therapy Gene Therapy RNA Therapeutics Antibody European Platforms
Insights & Perspectives

Thought Leadership

Perspectives on pharmaceutical partnerships, platform licensing, and the life science industry.

Thought Leadership March 2026 · 6 min read

How AI is Changing Pharmaceutical Partner Search

The business of finding the right development partner has always been relationship-driven. Artificial intelligence is not replacing those relationships — but it is fundamentally changing how they begin.

Traditional directory search operates on keywords. AI-powered partner search interprets intent — understanding capability depth, geography, regulatory framework and partnership stage simultaneously. A query like "Which European CDMOs handle cytotoxic ADC payload synthesis with GMP fill-finish for clinical stage programmes?" is understood in its entirety, not just matched on keywords.

The Partnership Tree was built specifically for the pharmaceutical and life science industry, combining two decades of directory expertise from The Pharma Services Directory — established in 2003 — with a purpose-built partner network for platform technology companies seeking licensing and co-development partners.

Discuss Partnership →
Drug Discovery March 2026 · 7 min read

How AI-Based Partnerships Are Changing Drug Discovery

Artificial intelligence is not just accelerating drug discovery — it is reshaping who does it, and how collaborations between technology companies and pharmaceutical developers are structured.

AI drug discovery companies are, almost by definition, partnership-dependent. The most sophisticated computational platform cannot take a drug to the clinic without wet laboratory validation, clinical expertise, regulatory knowledge and manufacturing capability.

This creates a structural need for partnerships that is different in character from traditional pharma-CDMO relationships — combining the AI company's discovery engine with the pharmaceutical partner's development infrastructure and commercial reach.

Read More in Member Portal →
Full Articles Available

More Insights in the Member Portal

Full articles, network news, partnership announcements and industry perspectives are available to members. Login or request access below.

Access Full Insights →